Hjem › Fokal segmental glomerulosklerose › Pennsylvania
Fokal segmental glomerulosklerose kliniske forsøg i Pennsylvania
9 studier for Fokal segmental glomerulosklerose søger deltagere på steder i Pennsylvania.
Byer i Pennsylvania
Officiel studietekst (engelsk)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #30, Bethlehem
- Investigator Site #19, Bridgeville
- Investigator Site #22, Butler
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07268638A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- Northeast Clinical Research Center, Bethlehem
- Clinical Renal Associates, Exton
- University of Pennsylvania, Philadelphia
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07220083Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- St. Christopher's Hospital for Children, Philadelphia
Rekrutterer
Op til 21 år · Alle køn · Opdateret 28. aug. 2026 · NCT02235857Nephrotic Syndrome Study Network
- Children's Hospital of Philadelphia, Philadelphia
- University of Pennsylvania, Philadelphia
- Temple University, Philadelphia
RekruttererObservationsstudie
Op til 80 år · Alle køn · Opdateret 10. jun. 2026 · NCT01209000NEPTUNE Match Study
- Hospital of the University of Pennsylvania, Philadelphia
- Temple University, Philadelphia
Rekrutterer
Alder 1 til 80 · Alle køn · Opdateret 10. jun. 2026 · NCT04571658Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Children's Hospital of Philadelphia, Philadelphia
RekruttererFase 2
Alder 1 til 17 · Alle køn · Opdateret 12. maj 2026 · NCT05003986A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)
- Children's Hospital of Philadelphia, Philadelphia
Rekrutterer
Alder 3 til 17 · Alle køn · Opdateret 17. apr. 2026 · NCT05583942taVNS for FRNS in Children
- Children's Hospital of Philadelphia, Philadelphia
Rekrutterer
Alder 3 til 17 · Alle køn · Opdateret 15. apr. 2026 · NCT05588063A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- The Childrens Hospital of Philadelphia Kohls GI Nutrition and Diagnostic Center, Philadelphia
RekruttererFase 3
Alder 12 til 80 · Alle køn · Opdateret 3. feb. 2026 · NCT05183646Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.